Clinic
Soledad Community Health Care District
Soledad Community Health Care District was paid $27.70M by Medicaid between Jan 2018 and Dec 2024, across 171 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 68% of everything it billed.
33Billing provider infoSOLEDAD COMMUNITY HEALTH CARE DISTRICT
SOLEDAD, CA 93960
SOLEDAD, CA 93960
33aNPI1003822453assigned 07/31/2006
33bProvider typeRural Health Clinic/Center
28Total paid$27.70M
24GClaims734,748
24DCodes billed171
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rural Health Clinic/Center providers in California
Rank by total paid#14 of 215
Median peer was paid$3.62M
This provider vs. median7.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 81,217 | $4.92M | |
| 2019 | 108,303 | $4.57M | |
| 2020 | 128,052 | $4.40M | |
| 2021 | 113,251 | $3.78M | |
| 2022 | 108,800 | $3.62M | |
| 2023 | 118,242 | $4.05M | |
| 2024incomplete | 76,883 | $2.37M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 68% | 156,194 | 126,652 | $18.76M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.2% | 60,786 | 41,019 | $1.43M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.8% | 89,639 | 58,576 | $1.34M |
| 59425 | 2.2% | 8,052 | 5,930 | $619K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.0% | 12,673 | 8,930 | $553K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.5% | 8,701 | 6,228 | $425K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.3% | 24,518 | 17,615 | $348K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.2% | 8,040 | 5,871 | $331K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.2% | 5,490 | 3,874 | $321K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 3,103 | 2,116 | $227K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 3,790 | 2,981 | $206K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 4,885 | 3,270 | $173K |
159 more codes
| 90686 | <1% | 13,505 | $168K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 6,717 | $148K |
| G9920 | Screening performed and negative | <1% | 7,988 | $147K |
| 92551 | <1% | 10,773 | $138K | |
| J3490 | Unclassified drugs | <1% | 1,148 | $134K |
| 92552 | <1% | 9,740 | $132K | |
| 97803 | <1% | 1,558 | $100K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,808 | $90K |
| 99188 | <1% | 6,848 | $87K | |
| 90670 | <1% | 7,040 | $85K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,841 | $77K |
| 99173 | <1% | 19,999 | $65K | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 5,676 | $64K |
| 99000 | <1% | 21,029 | $58K | |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 2,488 | $56K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,489 | $52K |
| 90651 | <1% | 1,355 | $50K | |
| 0012A | <1% | 973 | $50K | |
| 90633 | <1% | 4,200 | $48K | |
| 87634 | <1% | 1,235 | $46K | |
| 85018 | <1% | 36,657 | $46K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 8,143 | $43K |
| 90710 | <1% | 3,696 | $42K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 219 | $38K |
| 97802 | <1% | 282 | $37K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 8,176 | $36K |
| 90715 | <1% | 2,374 | $34K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 4,294 | $32K |
| 90648 | <1% | 2,042 | $31K | |
| 90649 | <1% | 1,989 | $30K | |
| 90681 | <1% | 2,852 | $30K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 611 | $28K |
| 0011A | <1% | 740 | $26K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 874 | $26K |
| 90698 | <1% | 2,770 | $25K | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | <1% | 5,230 | $22K |
| 0001A | <1% | 528 | $22K | |
| 90682 | <1% | 479 | $21K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,298 | $21K |
| 90723 | <1% | 1,278 | $21K | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 795 | $20K |
| 0002A | <1% | 478 | $20K | |
| 83655 | <1% | 2,500 | $19K | |
| 81002 | <1% | 20,451 | $19K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,302 | $19K |
| 90697 | <1% | 1,901 | $18K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,821 | $17K |
| 83013 | <1% | 470 | $17K | |
| Z7500 | <1% | 758 | $16K | |
| 86580 | <1% | 4,369 | $16K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 517 | $16K |
| 90734 | <1% | 1,357 | $16K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 219 | $15K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 137 | $14K |
| 90744 | <1% | 1,636 | $14K | |
| 90677 | <1% | 839 | $12K | |
| 81025 | <1% | 5,563 | $11K | |
| 87807 | <1% | 2,753 | $11K | |
| 80061 | Lipid panel | <1% | 2,012 | $11K |
| 90696 | <1% | 939 | $10K | |
| 90619 | <1% | 954 | $10K | |
| 90688 | <1% | 512 | $10K | |
| 90656 | <1% | 1,086 | $10K | |
| 99381 | <1% | 338 | $9K | |
| 0013A | <1% | 219 | $9K | |
| 96158 | <1% | 6,019 | $9K | |
| 82962 | <1% | 8,698 | $9K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 108 | $9K |
| 0071A | <1% | 177 | $9K | |
| 96127 | <1% | 2,515 | $9K | |
| 0072A | <1% | 150 | $9K | |
| 97804 | <1% | 238 | $8K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 64 | $8K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 883 | $8K |
| 90700 | <1% | 679 | $8K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 502 | $8K |
| 90620 | <1% | 442 | $6K | |
| 81003 | <1% | 2,855 | $6K | |
| 99401 | <1% | 318 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,042 | $6K |
| 11055 | <1% | 1,128 | $6K | |
| 87428 | <1% | 173 | $6K | |
| 0003A | <1% | 100 | $6K | |
| 11056 | <1% | 1,100 | $5K | |
| 90685 | <1% | 301 | $5K | |
| 90750 | <1% | 32 | $4K | |
| 96151 | <1% | 188 | $4K | |
| 69210 | <1% | 274 | $4K | |
| 90674 | <1% | 170 | $3K | |
| 90662 | <1% | 360 | $3K | |
| 81000 | <1% | 1,048 | $3K | |
| 76801 | <1% | 29 | $3K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 685 | $3K |
| G0109 | Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | <1% | 94 | $3K |
| 87430 | <1% | 664 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 151 | $3K |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 372 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 676 | $2K |
| 86480 | <1% | 7,624 | $2K | |
| 90716 | <1% | 116 | $2K | |
| 83014 | <1% | 427 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 231 | $2K |
| 90673 | <1% | 48 | $2K | |
| 59430 | <1% | 26 | $2K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 8,929 | $1K |
| 99307 | <1% | 1,537 | $1K | |
| 0134A | <1% | 14 | $938.00 | |
| 90672 | <1% | 68 | $936.00 | |
| 90707 | <1% | 65 | $776.80 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 240 | $689.40 |
| 93000 | <1% | 28 | $592.13 | |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 24 | $522.00 |
| 73030 | <1% | 16 | $408.47 | |
| 80305 | <1% | 68 | $390.72 | |
| G2010 | Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment | <1% | 63 | $356.21 |
| 90630 | <1% | 16 | $349.00 | |
| 90680 | <1% | 31 | $265.21 | |
| 99304 | <1% | 31 | $226.80 | |
| 99174 | <1% | 3,067 | $200.31 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,994 | $182.93 |
| 73564 | <1% | 16 | $162.86 | |
| 99070 | <1% | 112 | $155.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 20 | $145.44 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 33 | $114.64 |
| 36415 | Collection of venous blood by venipuncture | <1% | 336 | $112.18 |
| 11720 | <1% | 51 | $109.20 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 47 | $88.69 |
| 96160 | <1% | 2,358 | $80.27 | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 87 | $72.90 |
| 90461 | <1% | 5,598 | $71.18 | |
| 82044 | <1% | 12 | $57.25 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 18 | $46.24 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 19 | $45.00 |
| 94760 | <1% | 682 | $37.12 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 83 | $5.27 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 23 | $1.53 |
| 36416 | <1% | 393 | $1.15 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 209 | $0.26 |
| A4550 | Surgical trays | 0% | 412 | $0.00 |
| Z6400 | 0% | 157 | $0.00 | |
| Z6200 | 0% | 12 | $0.00 | |
| 3051F | 0% | 92 | $0.00 | |
| Z6304 | 0% | 171 | $0.00 | |
| Z6300 | 0% | 38 | $0.00 | |
| 90473 | 0% | 258 | $0.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 344 | $0.00 |
| 99499 | 0% | 12 | $0.00 | |
| 99442 | 0% | 30 | $0.00 | |
| 90791 | Psychiatric diagnostic evaluation | 0% | 21 | $0.00 |
| Z1034 | 0% | 5,198 | $0.00 | |
| 3044F | 0% | 2,580 | $0.00 | |
| Z6410 | 0% | 1,325 | $0.00 | |
| 96161 | 0% | 851 | $0.00 | |
| Z6406 | 0% | 130 | $0.00 | |
| Z6204 | 0% | 160 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 84 | $0.00 |
| Z1032 | 0% | 73 | $0.00 | |
| 99441 | 0% | 46 | $0.00 | |
| 3052F | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHAN, IDA (CHIEF EXECUTIVE OFFICER)
Parent organizationSOLEDAD COMMUNITY HEALTH CARE DISTRICT